U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new investigational drug for cannabis withdrawal syndrome.
Healthcare isn't the hottest sector these days. While the S&P 500 has soared nearly 21% over the last 12 months, healthcare ...
The Repository on MSN36m
Egg-cellent ideas: With costs up and shelves bare, here are great egg alternativesLearn more about egg safety at the shortened link, shorturl.at/V8BVC. Elisa Maloberti, food safety manager at the ...
Robert F. Kennedy Jr., the new U.S. health secretary, has promised to address an epidemic of chronic illness with President ...
1hOpinion
The F.D.A. is making its biggest move yet to end smoking. It needs to be careful not to give rise to another public health ...
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a healthcare stock. It opens up new growth opportunities for the business. And ...
President Trump’s war on reproductive health now has an enforcer. With Robert F. Kennedy Jr. now leading the Department of ...
Robert F. Kennedy Jr. was confirmed Thursday as President Trump’s health secretary amidst several ethics and disinformation ...
The GOP fell in line behind the president despite hesitancy over Kennedy's views on vaccines, voting 52-48, with Kentucky Sen ...
Hamilton, has filed a lawsuit against large tobacco companies alleging that they're not following an agreement and want to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback